Clinical application of multi-contrast 7-T MR imaging in multiple sclerosis: Increased lesion detection compared to 3 T confined to grey matter

European Radiology

Volumn 23, Issue 2, 2013, Pages 528-540

  De Graaf, Wolter L ^a   Kilsdonk, Iris D ^a   Lopez Soriano, Alexandra ^a   Zwanenburg, Jaco J M ^b,c   Visser, Fredy ^b,d   Polman, Chris H ^a   Castelijns, Jonas A ^a   Geurts, Jeroen J G ^a   Pouwels, Petra J W ^a   Luijten, Peter R ^b   Barkhof, Frederik ^a   Wattjes, Mike P ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^d PHILIPS HEALTHCARE   (United States)

Author keywords

High field MRI; Imaging, three dimensional methods; Magnetic resonance imaging; Multiple sclerosis diagnosis; Multiple sclerosis pathological features

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DIAGNOSTIC VALUE; FEMALE; GRAY MATTER; HUMAN; IMAGE ANALYSIS; MALE; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PRIORITY JOURNAL; PROSPECTIVE STUDY; SENSITIVITY ANALYSIS; SEVEN TESLA NUCLEAR MAGNETIC RESONANCE IMAGING; THREE TESLA NUCLEAR MAGNETIC RESONANCE IMAGING; WHITE MATTER;

EID: 84878566112     PISSN: 09387994     EISSN: 14321084     Source Type: Journal    
DOI: 10.1007/s00330-012-2619-7     Document Type: Article

References (40)

1. Compston A, Coles A (2002) Multiple sclerosis. Lancet 359:1221-1231
2. Young I, Hall A, Pallis C, Legg N, Bydder G, Steiner R (1981) Nuclear magnetic resonance imaging of the brain in multiple sclerosis. Lancet 14:1063-1066
3. Bakshi R, Thompson AJ, Rocca MA, Pelletier D, Dousset V, Barkhof F, Inglese M, Guttmann CRG, Horsfield MA, et al. (2008) MRI in multiple sclerosis: current status and future prospects. Lancet Neurol 7:615-625
4. McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, Lublin FD, McFarland HF, Paty DW, Polman CH, et al. (2001) Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 50:121-127
5. Polman CH, Reingold SC, Edan G, Filippi M, Hartung H-P, Kappos L, Lublin FD, Metz LM, Mcfarland HF, et al. (2005) Diagnostic criteria for multiple sclerosis: 2005 revisions to the McDonald Criteria. Ann Neurol 58:840-846
6. Polman CH, Reingold SC, Banwell B, Clanet M, Cohen JA, Filippi M, Fujihara K, Havrdova E, Hutchinson M, et al. (2011) Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 69:292-302
7. Wattjes MP, Barkhof F (2009) High field MRI in the diagnosis of multiple sclerosis: high field-high yield? Neuroradiology 51:279-292
8. Wattjes MP, Lutterbey GG, Harzheim M, Gieseke J, Träber F, Klotz L, Klockgether T, Schild HH (2006) Higher sensitivity in the detection of inflammatory brain lesions in patients with clinically isolated syndromes suggestive of multiple sclerosis using high field MRI: an intraindividual comparison of 1.5 T with 3.0 T. Eur Radiol 16:2067-2073
9. Di Perri C, Dwyer MG, Wack DS, Cox JL, Hashmi K, Saluste E, Hussein S, Schirda C, Stosic M, et al. (2009) Signal abnormalities on 1.5 and 3 Tesla brain MRI in multiple sclerosis patients and healthy controls. A morphological and spatial quantitative comparison study. NeuroImage 47:1352-1362
10. Minneboo A, Barkhof F, Polman CH, Uitdehaag BMJ, Knol DL, Castelijns JA (2004) Infratentorial lesions predict long-term disability in patients with initial findings suggestive of multiple sclerosis. Arch Neurol 61:217-221
11. Kilsdonk ID, de Graaf WL, Barkhof F, Wattjes MP (2012) Inflammation high-field magnetic resonance imaging. Neuroimaging Clin N Am 22:135-157
12. Kollia K, Maderwald S, Putzki N, Schlamann M, Theysohn JM, Kraff O, Ladd ME, Forsting M, Wanke I (2009) First clinical study on ultra-high-field MR imaging in patients with multiple sclerosis: comparison of 1.5 T and 7 T. AJNR. Am J Neuroradiol 30:699-702
13. Ge Y, Zohrabian VM, Grossman RI (2008) Seven-Tesla magnetic resonance imaging: new vision of microvascular abnormalities in multiple sclerosis. Arch Neurol 65:812-816
14. Tallantyre EC, Brookes MJ, Dixon JE, Morgan PS, Evangelou N, Morris PG (2008) Demonstrating the perivascular distribution of MS lesions in vivo with 7-Tesla MRI. Neurology 70:2076-2078
15. Hammond KE, Metcalf M, Carvajal L, Okuda DT, Srinivasan R, Vigneron D, Nelson SJ, Pelletier D (2008) Quantitative in vivo magnetic resonance imaging of multiple sclerosis at 7 Tesla with sensitivity to iron. Ann Neurol 64:707-713
16. Yao B, Bagnato F, Matsuura E, Merkle H, van Gelderen P, Cantor FK, Duyn JH (2012) Chronic multiple sclerosis lesions: characterization with high-field-strength MR imaging. Radiology 262:206-215
17. Pitt D, Boster A, Pei W, Wohleb E, Jasne A, Zachariah CR, Rammohan K, Knopp MV, Schmalbrock P (2010) Imaging cortical lesions in multiple sclerosis with ultra-high-field magnetic resonance imaging. Arch Neurol 67:812-818
18. Mainero C, Benner T, Radding A, van der Kouwe A, Jensen R, Rosen BR, Kinkel RP (2009) In vivo imaging of cortical pathology in multiple sclerosis using ultra-high field MRI. Neurology 73:941-948
19. Metcalf M, Xu D, Okuda DT, Carvajal L, Srinivasan R, Kelley DAC, Mukherjee P, Nelson SJ, Vigneron DB, et al. (2010) High-resolution phased-array MRI of the human brain at 7 Tesla: initial experience in multiple sclerosis patients. J Neuroimaging 20:141-147
20. Tallantyre EC, Morgan PS, Dixon JE, Al-Radaideh A, Brookes MJ, Morris PG, Evangelou N (2010) 3 Tesla and 7 Tesla MRI of multiple sclerosis cortical lesions. J Magn Reson Imaging 32:971-977
21. Nielsen AS, Kinkel RP, Tinelli E, Benner T, Cohen-Adad J, Mainero C (2012) Focal cortical lesion detection in multiple sclerosis: 3 tesla DIR versus 7 Tesla FLASH-T2*. J Magn Reson Imaging 35:537-542
22. Simon JH, Li D, Traboulsee A, Coyle PK, Arnold DL, Barkhof F, Frank JA, Grossman R, Paty DW, et al. (2006) Standardized MR imaging protocol for multiple sclerosis: Consortium of MS Centers consensus guidelines. AJNR Am J Neuroradiol 27:455-461
23. Visser F, Zwanenburg JJM, Hoogduin JM, Luijten PR (2010) High-resolution magnetization-prepared 3D-FLAIR imaging at 7.0 Tesla. Magn Reson Med 64:194-202
24. Geurts JJG, Roosendaal SD, Calabrese M, Ciccarelli O, Agosta F, Chard DT, Gass A, Huerga E, Moraal B, et al. (2011) Consensus recommendations for MS cortical lesion scoring using double inversion recovery MRI. Neurology 76:418-424
25. Kurtzke J (1983) Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33:1444-1452
26. de Graaf WL, Zwanenburg JJM, Visser F, Wattjes MP, Pouwels PJW, Geurts JJG, Polman CH, Barkhof F, Luijten PR, et al. (2012) Lesion detection at seven Tesla in multiple sclerosis using magnetisation prepared 3D-FLAIR and 3D-DIR. Eur Radiol 22:221-231
27. Wattjes MP, Harzheim M, Lutterbey GG, Hojati F, Simon B, Schmidt S, Schild HH, Barkhof F (2008) Does high field MRI allow an earlier diagnosis of multiple sclerosis? J Neurol 255:1159-1163
28. Kilsdonk ID, Barkhof F, Wattjes MP (2011) 2010 Revisions to McDonald criteria for diagnosis of MS: impact of 3 Tesla MRI. Ann Neurol 70:182-183
29. Montalban X, Tintoré M, Swanton J, Barkhof F, Fazekas F, Filippi M, Frederiksen J, Kappos L, Palace J, et al. (2010) MRI criteria for MS in patients with clinically isolated syndromes. Neurology 74:427-434
30. Simon B, Schmidt S, Lukas C, Gieseke J, Träber F, Knol DL, Willinek WA, Geurts JJG, Schild HH, et al. (2010) Improved in vivo detection of cortical lesions in multiple sclerosis using double inversion recovery MR imaging at 3 Tesla. Eur Radiol 20:1675-1683
31. Calabrese M, Gallo P (2009) Magnetic resonance evidence of cortical onset of multiple sclerosis. Mult Scler 15:933-941
32. Calabrese M, Rocca MA, Atzori M, Mattisi I, Bernardi V, Favaretto A, Barachino L, Romualdi C, Rinaldi L, et al. (2009) Cortical lesions in primary progressive multiple sclerosis: a 2-year longitudinal MR study. Neurology 72:1330-1336
33. Calabrese M, Rocca MA, Atzori M, Mattisi I, Favaretto A, Perini P, Gallo P, Filippi M (2010) A 3-year magnetic resonance imaging study of cortical lesions in relapse-onset multiple sclerosis. Ann Neurol 67:376-383
34. Lucchinetti CF, Popescu BFG, Bunyan RF, Moll NM, Roemer SF, Lassmann H, Brück W, Parisi JE, Scheithauer BW, et al. (2011) Inflammatory cortical demyelination in early multiple sclerosis. N Engl J Med 365:2188-2197
35. Calabrese M, Agosta F, Rinaldi F, Mattisi I, Grossi P, Favaretto A, Atzori M, Bernardi V, Barachino L, et al. (2009) Cortical lesions and atrophy associated with cognitive impairment in relapsing-remitting multiple sclerosis. Arch Neurol 66:1144-1150
36. Roosendaal SD, Moraal B, Pouwels PJW, Vrenken H, Castelijns JA, Barkhof F, Geurts JJG (2009) Accumulation of cortical lesions in MS: relation with cognitive impairment. Mult Scler 15:708-714
37. Filippi M, Rocca MA, Calabrese M, Sormani MP, Rinaldi F, Perini P, Comi G, Gallo P (2010) Intracortical lesions: relevance for new MRI diagnostic criteria for multiple sclerosis. Neurology 75:1988-1994
38. Geurts JJG, Pouwels PJW, Uitdehaag BMJ, Polman CH, Barkhof F, Castelijns JA (2005) Intracortical lesions in multiple sclerosis: improved detection with 3D double inversion-recovery MR imaging. Radiology 236:254-260
39. Tallantyre EC, Morgan PS, Dixon JE, Al-Radaideh A, Brookes MJ, Evangelou N, Morris PG (2009) A comparison of 3 T and 7 T in the detection of small parenchymal veins within MS lesions. Invest Radiol 44:491-494
40. Ropele S, de Graaf W, Khalil M, Wattjes MP, Langkammer C, Rocca MA, Rovira A, Palace J, Barkhof F, et al. (2011) MRI assessment of iron deposition in multiple sclerosis. J Magn Reson Imaging 34:13-21